At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Recombinant Human Leptin Therapy Effects on Insulin Action
In Brief
A clinical study evaluating placebo, low-dose leptin, and 1 other intervention for Type Two Diabetes Mellitus. Completed, enrolled 18 participants across 1 site.
Detailed Summary
Leptin therapy improves insulin sensitivity in people with leptin-deficiency but it is not known whether it improves insulin action in persons who are not leptin deficient. The purpose of the present study was to determine whether leptin therapy has effects on insulin action in obese subjects with type 2 diabetes mellitus (T2DM). A randomized, placebo controlled trial was conducted in obese subjects with newly-diagnosed T2DM. Subjects were randomized to treatment with placebo, low-dose, or high-dose leptin. Insulin sensitivity was measured.
Study Details
Timeline
Interventions
saline placebo
30mg per day of recombinant methionyl human (r-met hu) leptin for fourteen days
80mg per day of recombinant methionyl human (r-met hu) leptin for fourteen days